Acesse o fluxograma na íntegra fazendo o download do documento.

Fonte: Ministério da Saúde 

Paciente com qualquer sintoma de sídrome gripal.

Acesse o fluxo na íntegra fazendo o download do documento.

Fonte: Ministério da Saúde 

O documento orienta sobre as medidas de prevenção, como proceder e onde procurar ajuda em situações de casos suspeitos e/ou confirmados ou diante do agravamento de saúde. A Secretaria de Estado de Saúde (SES-RJ) elaborou o documento em colaboração com a Escola Politécnica de Saúde Joaquim Venâncio, referência nacional na formação de Agentes Comunitários de Saúde.

Leia as orientações na íntegra acessando a página descrita no link.

Fonte: Secretaria de Estado de Saúde do Rio de Janeiro (SES-RJ)

Após o crescente número de casos e a declaração do diretor-geral da Organização Mundial da Saúde (OMS), no dia 11 de março de 2020, em Genebra, na Suíça, que a COVID-19, doença causada pelo novo Coronavírus (2019-nCoV), é agora caracterizada como uma pandemia, fica ainda mais premente a orientação pelo Ministério da Saúde ao funcionamento dos serviços e equipes de saúde.

Background- There are few primary care studies of the COVID-19 pandemic. We aimed to identify demographic and clinical risk factors for testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre primary care network.

Lockdowns caused by the coronavirus disease 2019 (COVID-19) have turned the lives of people around the world upside down. Yet, for those living with diabetes, the movement restrictions have raised a whole series of extra questions: how can they seek advice; how can their health be monitored; and how can they continue to manage their condition? Healthcare professionals and those who support people with diabetes have rallied during the lockdown to find innovative ways to help.

Widespread reports of disproportionate impact of the COVID-19 pandemic among already vulnerable communities worldwide, from New York City to New Orleans and Chicago, to the shocking pictures of bodies lying in the streets in Ecuador, represent a prelude of the impact in low-income and middle-income countries, home to more than 80% of the world's population. Disadvantaged people are at higher risk of infection and death from COVID-19, and they have less access to care due to systems that treat health as a commodity and not a human right.

In December, 2019, an outbreak of the novel coronavirus (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) occurred in Wuhan, China, and soon spread all over the world. Rapid and accurate diagnosis of SARS-CoV-2 infection is the cornerstone of all efforts to stem its advancement.

The detailed report by Timothy Harkin and colleagues of an unusual case of respiratory illness eventually diagnosed as COVID-19 raises issues about the role of imaging in the management of the disease. The causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can result in lethal pneumonia, so might chest imaging have a central role in the detection or management of COVID-19? Is there a signature imaging appearance of the virus that could alert radiologists to its presence?

The novel coronavirus disease 2019 (COVID-19), caused by the pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China, and has now spread internationally with over 4·3 million individuals infected and over 297 000 deaths as of May 14, 2020, according to the Johns Hopkins Coronavirus Resource Center.